- Home
- ETON vs TIL Comparison
ETON vs TIL Comparison
Compare ETON & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- TIL
- Stock Information
- Founded
- ETON 2017
- TIL 2018
- Country
- ETON United States
- TIL United States
- Employees
- ETON N/A
- TIL N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ETON Health Care
- TIL Health Care
- Exchange
- ETON Nasdaq
- TIL Nasdaq
- Market Cap
- ETON 428.5M
- TIL 230.1M
- IPO Year
- ETON 2018
- TIL 2021
- Fundamental
- Price
- ETON $14.45
- TIL $28.50
- Analyst Decision
- ETON Strong Buy
- TIL Buy
- Analyst Count
- ETON 3
- TIL 5
- Target Price
- ETON $29.67
- TIL $119.00
- AVG Volume (30 Days)
- ETON 616.4K
- TIL 349.6K
- Earning Date
- ETON 08-07-2025
- TIL 08-12-2025
- Dividend Yield
- ETON N/A
- TIL N/A
- EPS Growth
- ETON N/A
- TIL N/A
- EPS
- ETON N/A
- TIL N/A
- Revenue
- ETON $48,327,000.00
- TIL N/A
- Revenue This Year
- ETON $103.21
- TIL N/A
- Revenue Next Year
- ETON $51.34
- TIL N/A
- P/E Ratio
- ETON N/A
- TIL N/A
- Revenue Growth
- ETON 40.88
- TIL N/A
- 52 Week Low
- ETON $3.22
- TIL $9.62
- 52 Week High
- ETON $21.48
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ETON 41.91
- TIL 52.42
- Support Level
- ETON $13.51
- TIL $20.60
- Resistance Level
- ETON $14.70
- TIL $31.67
- Average True Range (ATR)
- ETON 0.78
- TIL 3.88
- MACD
- ETON 0.11
- TIL -1.08
- Stochastic Oscillator
- ETON 79.53
- TIL 42.47
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.